Convatec is a global leader in medical products and technologies, dedicated to providing innovative solutions for the management of chronic conditions. With a strong focus on advanced wound care, ostomy care, continence care, and infusion care, Convatec operates in nearly 100 countries and employs around 10,000 people. The company is committed to improving patient outcomes and reducing care costs, generating over $2 billion in revenue in 2023. As a constituent of the FTSE 100 Index, Convatec is on a transformative journey to enhance its products and services, fostering a culture of excellence and collaboration among its teams. The company values equal opportunities and is dedicated to making a positive impact on the lives of millions of customers worldwide.